Quantcast

Latest Biodefense Stories

2011-01-13 08:00:00

ANNAPOLIS, Md., Jan. 13, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company recently presented new data from its anthrax anti-toxin and recombinant Protective Antigen (rPA) anthrax vaccine programs at the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop and the Biomedical Advanced Research and Development...

2011-01-10 15:30:00

ANNAPOLIS, Md., Jan. 10, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has strengthened its research and development and program management functions with the addition of several new leadership appointments. Namely, Ms. Susan Linna has been appointed Vice President of Program Management; Dr. Kevin Connolly has joined the organization as Senior Program Director for rPA-based anthrax vaccines; and Dr. Kimberly Taylor has joined the organization as Senior...

2010-12-02 08:27:00

CHICAGO, Dec. 2, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that Dawson James Securities Inc., has initiated analyst research coverage of Advanced Life Sciences. The report highlights Restanza(TM) (cethromycin) as a promising late-stage antibacterial...

2010-11-22 06:00:00

PRINCETON, N.J., Nov. 22, 2010 /PRNewswire/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has granted patent #7,829,668, entitled "Compositions and methods for modifying toxic effects of proteinaceous compounds." This patent includes composition claims for the modified ricin toxin A chain which is the immunogen contained in RiVax(TM). Conceived by...

2010-11-09 07:30:00

CHICAGO, Nov. 9, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has submitted a full proposal to the National Institute of Allergy and Infectious Diseases (NIAID) under BAA-NIAID-DMID-NIHAI2010097 Development Of Therapeutics For Biodefense. It is...

2010-11-02 06:00:00

PRINCETON, N.J., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin Board: SNGX), a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax(TM), a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax(TM) appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation...

2010-10-21 09:22:00

ANNAPOLIS, Md., Oct. 21 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company's Board of Directors has appointed Eric I. Richman to the position of President and Chief Executive Officer, effective immediately. Mr. Richman was previously appointed President and Interim Chief Executive Officer in May 2010, and prior thereto served as the Company's...

2010-10-08 02:00:45

Research to focus on improving delivery of dengue and anthrax vaccines The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack. Each project focuses on simple and efficient vaccine delivery approaches that could be deployed quickly. The total funding for the three...

2010-10-04 08:00:00

CHICAGO, Oct. 4 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the company provided testimony at the U.S. Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services (HHS) Hearing on "Defending Against Public Health Threats" on...

2010-09-02 07:00:00

PRINCETON, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA). An inactivated form of RTA is the primary component of RiVax(TM), the Company's proprietary vaccine against ricin...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.